FMR CORP 13D/13G Filings for Viking Therapeutics, Inc. (VKTX)

FMR CORP 13D and 13G filings for Viking Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-02-09
10:05 am
Purchase		 2024-02-08 13G Viking Therapeutics, Inc.
VKTX		 FMR CORP 15,004,340
14.999%		 4,081,593increase
(+37.37%)		 Filing
2023-04-10
09:37 am
Purchase		 2023-04-06 13G Viking Therapeutics, Inc.
VKTX		 FMR CORP 10,922,747
11.418%		 8,736,380increase
(+399.58%)		 Filing